Quantitative Investment Management LLC Invests $11.26 Million in Steris Plc (STE) Stock
Quantitative Investment Management LLC bought a new stake in Steris Plc (NYSE:STE) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 138,200 shares of the medical equipment provider’s stock, valued at approximately $11,263,000. Quantitative Investment Management LLC owned 0.16% of Steris Plc as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of STE. First Trust Advisors LP increased its stake in Steris Plc by 14.0% in the first quarter. First Trust Advisors LP now owns 8,593 shares of the medical equipment provider’s stock valued at $597,000 after acquiring an additional 1,055 shares during the period. Suntrust Banks Inc. increased its stake in Steris Plc by 29.3% in the first quarter. Suntrust Banks Inc. now owns 7,395 shares of the medical equipment provider’s stock valued at $512,000 after acquiring an additional 1,675 shares during the period. Karp Capital Management Corp bought a new stake in Steris Plc in the first quarter valued at about $1,553,000. Ameriprise Financial Inc. increased its stake in Steris Plc by 9.2% in the first quarter. Ameriprise Financial Inc. now owns 250,265 shares of the medical equipment provider’s stock valued at $17,383,000 after acquiring an additional 21,036 shares during the period. Finally, Parametric Portfolio Associates LLC increased its stake in Steris Plc by 18.6% in the first quarter. Parametric Portfolio Associates LLC now owns 23,513 shares of the medical equipment provider’s stock valued at $1,633,000 after acquiring an additional 3,683 shares during the period. 93.33% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/21/quantitative-investment-management-llc-invests-11-26-million-in-steris-plc-ste-stock.html.
In related news, VP Karen L. Burton sold 3,270 shares of Steris Plc stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $85.70, for a total transaction of $280,239.00. Following the sale, the vice president now directly owns 11,807 shares of the company’s stock, valued at approximately $1,011,859.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael B. Wood sold 4,000 shares of Steris Plc stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $81.50, for a total transaction of $326,000.00. Following the sale, the director now directly owns 26,131 shares in the company, valued at $2,129,676.50. The disclosure for this sale can be found here. Insiders have sold a total of 176,086 shares of company stock worth $15,297,621 over the last ninety days. 2.55% of the stock is currently owned by insiders.
Steris Plc (STE) opened at 87.08 on Thursday. Steris Plc has a 52-week low of $63.80 and a 52-week high of $88.11. The firm has a 50-day moving average of $85.66 and a 200-day moving average of $78.30. The firm has a market capitalization of $7.42 billion, a price-to-earnings ratio of 62.29 and a beta of 1.29.
Steris Plc (NYSE:STE) last released its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the consensus estimate of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The firm had revenue of $608.00 million for the quarter, compared to analyst estimates of $597.66 million. During the same period last year, the firm earned $0.79 EPS. The business’s quarterly revenue was down 4.8% compared to the same quarter last year. On average, equities research analysts forecast that Steris Plc will post $4.06 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be issued a $0.31 dividend. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 1.42%. The ex-dividend date is Friday, August 25th. Steris Plc’s dividend payout ratio (DPR) is currently 88.57%.
A number of analysts recently weighed in on STE shares. BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price on the stock in a research note on Tuesday, July 11th. Wellington Shields cut shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Finally, Raymond James Financial, Inc. upped their target price on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $86.75.
Steris Plc Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Stock Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related stocks with our FREE daily email newsletter.